Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
BTC vs ETH fundamentals: a side-by-side look at core strengths and weaknesses to inform your next move.
27,640 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
Cerebras exploded higher on its debut, but what comes next for investors? This guide breaks down the hype, the fundam...
When a chief financial officer sells a sizable stake, investors take notice. This article breaks down Shoals Technolo...
A Franklin Electric insider sold 1,900 shares for about $190k, prompting questions about FELE. This guide explains in...
Earnings season often brings volatility, but a post-earnings sell-off could incredible offer a rare entry point for p...
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
A Northeast bank insider sold 12,190 shares for about $817k, signaling more than a single move. Learn what it could m...
When a large hedge fund reduces its Celcuity stake, markets pay attention. This article breaks down the move, what it...
Sable Offshore stock tanked over the last year as oil markets swung and investors weighed long-term offshore exposure...
When a hedge fund boosts its holdings, investors pay attention. This piece explains why Bridge City nearly tripled it...